Key Findings
The North America influenza vaccine market is anticipated to reach a CAGR of 6.06% over the projected period of 2020-2028. The growing number of cases of influenza is one of the significant factors augmenting market growth in the region.

Market Insights
The North America influenza vaccine market is further surveyed by segregating the region into the United States and Canada. In Canada, according to the experts, a type of influenza B had started circulating at the same rate as influenza A at the end of 2019, which is unusual as influenza B does not circulate until late in the season. This has caused concern among the experts as influenza B leads to a higher risk of hospitalization and deaths among children. The recent Flu Watch report published by PHAC in January 2020 explains the link between increased presence of influenza B and higher pediatric illnesses and hospitalizations. As per the PHAC, a similar number of pediatric hospitalizations due to influenza A were reported this season as compared to previous years. In Canada, the funding for childhood and adult immunization programs for influenza vaccines is different. Most of the pediatric immunization programs are publicly funded through public health programs and physician offices. Public funding for adults is limited, and patients often request for vaccines from their healthcare providers and physician offices. Moreover, certain vaccines are covered under private insurance plans or by the employer, specifically those recommended for specific risk situations such as occupation or travel, and are not publically funded.

Competitive Insights
Pfizer Inc, Abbott, Merck, Emergent Biosolutions, CSL Ltd, etc. are some of the renowned companies operating in the market.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments